All posts by: Michael Zand

About Michael Zand

TissueGene awarded $750000 Maryland Stem Cell Grant for Invossa clinical study – BSA bureau (press release)

Continue reading

2017-07-03 NEWS

BSA bureau (press release)

TissueGene awarded $750000 Maryland Stem Cell Grant for Invossa clinical study
BSA bureau (press release)
Singapore – TissueGene, Inc., a US-based regenerative medicine company, announced that the Maryland Stem Cell Research Fund (MSCRF) has awarded TissueGene a clinical grant for Invossa, the world’s first cell and gene therapy for degenerative …

Continue reading

2017-07-03 NEWS

Global CRISPR Market: How the Market has witnessed Substantial Growth in recent years and What Factors will drive …
Medgadget (blog)
“Global CRISPR Market Size, Status and Forecast 2022”Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. This report presents a 360-degree overview of the competitive scenario of the Global CRISPR market. Thus helping …

and more »

Continue reading

2017-07-03 NEWS

The News (subscription)

Doctors to offer stem cell treatments
The News (subscription)
“World-wide the results with stem cells are off the charts. There are different types of stem cells … blood marrow, which is best used for blood diseases. Amniotic, which is the membrane surrounding the placenta and is the safeguard between the